CHATHAM, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology company, announced today ...

Treatment was well tolerated with minimal effects on weight or blood pressure and discontinuation rate of 19% vs. placebo of 20.8% Data support the potential of Tonmya as a well-tolerated, centrally ...

Buprenorphine sublingual tablet is prescribed to treat opioid use disorder in two phases: an induction phase to manage initial withdrawal symptoms and a maintenance phase for long-term treatment. You ...

Stallergenes Greer and Nuance Pharma Enter Exclusive Long-term Partnership for Actair® Sublingual Immunotherapy Tablet for the Treatment of House Dust Mite Allergy in China Stallergenes Greer, a ...

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in more than 15 years. (HealthDay News) — The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine ...

The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults. The approval is the first for a fibromyalgia ...

A novel formulation of the muscle relaxant drug cyclobenzaprine has won FDA approval for treating fibromyalgia, manufacturer Tonix Pharmaceuticals announced on Friday. To be sold as Tonmya, the ...

Regardless of where you're at in your studies, a great tablet can be a major asset to your learning and note-taking (and can even provide a little entertainment on the side). But with so many options ...

The FDA has approved cyclobenzaprine hydrochloride sublingual tablets (Tonmya, Tonix Pharmaceuticals), a first-in-class, nonopioid treatment for adults with fibromyalgia, a chronic pain syndrome that ...

TNX-102 SL is the first new fibromyalgia treatment approved in over 15 years, joining three other treatments. Phase 3 trials showed significant pain reduction and good tolerance, with improvements in ...

CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug ...

Android tablets have entered a new phase in 2025. Manufacturers are no longer pushing out half-hearted iPad alternatives. Instead, they are launching serious machines with flagship processors, premium ...